Toggle Nav
My Cart
English
Español
Menu
Account
  • Log in / Register
    • Language
    English
    Español

    CanniMed Therapeutics: Acquiror or Target

    Stephen Sapp ; Shane Freedman

    • Reference: IVEY-9B20N008-E

    • Year: 2017

    • Number of pages: 20

    • Geographic Setting: Canada

    • Publication Date: May 15, 2020

    • Fecha de edición: May 15, 2020

    • Source: Ivey Business School (Canada)

    • Type of Document: Case

    • Industry Setting: Arts, Entertainment, Sports and Recreation;

    Grouped product items
    Format Language Reference Use Qty Price Preview
    pdf English IVEY-9B20N008-E
    As low as €8.20
    		Preview

    You already have a subscription
    To order please contact the person in charge of academic purchases in your university.
    You'll be able to order once your profile has been validated.

    Description

    On November 14, 2017, Aurora Cannabis Inc. (Aurora) made a proposal to CanniMed Therapeutics Inc. (CanniMed) to acquire all of CanniMed’s issued and outstanding common shares in a share exchange that valued CanniMed’s common shares at a premium of almost

    Learning Objective

    This case can be used in undergraduate- and graduate-level courses on investment banking, valuation, emerging industries, or advanced corporate finance.The case addresses many of the challenges faced by firms in rapidly growing industries. Although a prim

    Keywords

    hostile takeover Mergers and Acquisitions Valuation valuing emerging industries